Valiant Laboratories Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last four quarters indicates strong demand for products.
Improved operating margins suggest better cost management and operational efficiency.
Increased R&D investment shows commitment to innovation and long-term growth.

NEGATIVES

Declining net profit margin raises concerns about profitability sustainability.
High debt levels could pose risks, particularly in a rising interest rate environment.
Fluctuating raw material costs might impact future profitability and pricing strategies.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	89.92	51.41	59.55	40.52	30.59	18.88	21.48	35.23	57.79	46.82
Expenses	81.31	47.59	60.93	46.82	35.12	21.27	28.22	34.61	53.96	44.42
Operating Profit	8.61	3.82	-1.39	-6.31	-4.53	-2.39	-6.74	0.62	3.83	2.40
Other Income	1.72	2.44	2.96	1.77	2.50	2.81	3.36	1.58	-2.31	0.66
Interest	0.03	0.02	0.02	0.02	0.02	0.05	0.01	0.06	0.06	0.07
Depreciation	0.44	0.46	0.49	0.49	0.52	0.53	0.52	0.52	0.52	0.53
Profit Before Tax	9.87	5.78	1.06	-5.04	-2.57	-0.16	-3.91	1.62	0.94	2.45
Tax	2.04	1.51	0.27	-1.54	-1.33	0.35	0.83	-0.73	0.24	0.63
Net Profit	7.83	4.27	0.79	-3.50	-1.24	-0.51	-4.74	2.34	0.70	1.82
Eps in Rs	2.41	1.31	0.24	-0.81	-0.33	-0.12	-1.09	0.54	0.16	0.42